Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

AIM: To investigate the effects of a novel Leukotriene B4 receptor antagonist and/or tacrolimus on ischemia-reperfusion in a rat liver model. METHODS: Male Lewis rats were pretreated with ONO-4057 (100 mg/kg) and/or tacrolimus (1 mg/kg) orally, and divided into four experimental groups; group 1 (control), group 2 (ONO-4057), group 3 (tacrolimus), group 4 (ONO-4057 + tacrolimus). RESULTS: There was a tendency for long survival in the groups treated with tacrolimus alone and ONO-4057 plus tacrolimus. Post-reperfusion serum aspartate aminotransferase levels decreased more significantly in ONO-4057 plus tacrolimus group (P < 0.01), than in the tacrolimus alone group (P < 0.05), compared to controls. CONCLUSION: This study demonstrated that pretreatment with ONO-4057 in combination with tacrolimus produced additive effects in a rat model of liver ischemia-reperfusion injury. © 2009 The WJG Press and Baishideng. All rights reserved.

Cite

CITATION STYLE

APA

Takeichi, T., Uemoto, S., Minamiguchi, S., Takeyoshi, I., Inomata, Y., Tanaka, K., & Kobayashi, E. (2009). Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver. World Journal of Gastroenterology, 15(45), 5712–5715. https://doi.org/10.3748/wjg.15.5712

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free